The Cancer SIGNAL, a new podcast from GRAIL, will explore all things related to multi-cancer early detection (#MCED). Host Kim Thiboldeaux, former CEO of Cancer Support Community, will interview experts from the oncology community each month - coming this October! bit.ly/3Lx4g6t

The 2022 Nixon National Cancer Conference begins this week! Tune in this Thursday at 2:30 PM PT to hear from William G. Cance, Distinguished Scientist GRAIL Watch it live here: youtube.com/watch?v=WvakRI…

Great to be with @LhPeng, Bill Cance and David Agus at today's @NixonFoundation Tech in Medicine Panel. Enjoyed moderating a superb discussion on the impact of quality and real world data, patient inclusion, and talent dependencies to advance medicine. Thanks for having me!

White House #CancerMoonshot just highlighted important government actions, and private sector progress, towards the President's goals to reduce the death rate from cancer by at least 50% over the next 25 years and "end cancer as we know it today."

For a more in depth understanding of how the Galleri test’s process works, check out our latest #podcast episode: bit.ly/3FNUo67 #TheCancerSignal

It is difficult to detect cancer early since most cancers do not have screening tests. A new NORC analysis finds just 1 in 7 diagnosed cancers are found by a screening test. ow.ly/9put50M3Hme

Congrats to University of Jerusalem, GRAIL, and @Illumina teams on the world’s most comprehensive atlas of human cell type methylomes, revealing thousands of #methylation sites. It was a personal privilege to contribute to this foundational science. nature.com/articles/s4158…

New results from the PATHFINDER clinical trial suggest that Galleri, a new multicancer #earlydetection blood test, can accurately identify the presence of more than 50 cancer types in apparently healthy people. Learn more: bit.ly/3Qnep8i #AVBCC

At yesterday’s media day for the Galleri Classic, our CEO Bob Ragusa shared a powerful reminder of the cause that's bringing us together: detecting cancer early, when it can be cured. To learn more about the #GalleriClassic, visit thegallericlassic.com. #MCED

Think you’ve got what it takes to take on the best of the best from the PGA TOUR Champions? Put your skills to the test in the inaugural Galleri Classic Pro-Am! Learn more at the link in our bio 🔗 MissionHillsCC #getoutandgolf #progolftour #desertgolf #golfersparadise

Happy birthday GRAIL! Yesterday we celebrated GRAIL's 7th birthday, gathering across our sites and virtually with remote employees. Thank you to all our teams whose commitment and passion bring us closer to changing the trajectory of cancer mortality.

Day 2 of the inaugural Galleri Classic is in the books and Bernhard Langer is chasing his 46th PGA TOUR Champions win.   Will he make history tomorrow at historic MissionHillsCC ? Be there to find out. #langer46

Talk about a game changer. The Galleri Classic is proud to announce that Desert Regional Medical Center will be offering our title sponsor’s early-detection cancer test. Learn more by clicking the link below. Galleri Test GRAIL desertsun.com/story/news/hea…

Thank you to Galleri Test and the The Galleri Classic for having me at the inaugural tournament. As a professional golfer whose dad passed from late-stage cancer, I have a passion for golf and early detection so this has truly been an unforgettable week for me.

This week on the #InsideOutPodcast, I’m joined by Josh Ofman, President of GRAIL, as we discuss their partnership with the @PINC_AI team to support patient access and the latest #innovations in cancer detection. Listen here: insideout.premierinc.com

70% of cancer deaths are from cancers without recommended screening, including many uncommon cancer types. On #TheCancerSignal, guests from American Cancer Society and GRAIL discuss cancer risk and the role of #MCED. 🎙️ Download or listen: bit.ly/3nUhnHb

At #AACR23 we’re presenting a late-breaking poster session and 5 additional poster sessions showcasing how our targeted methylation technology supports cancer signal detection in pre- and post-diagnosis settings. Find out more: bit.ly/41meqNQ #MCED #DetectCancerEarly

The best way to stay up to date on all things GRAIL is with our monthly newsletter - sign up here: bit.ly/3KFsxaF

Dr. Earl Hubbell, Distinguished Scientist, Bioinformatics at GRAIL, was recognized in the Best of AACR Journals for his work evaluating the impact of adding #MCED testing to usual cancer care. Check out his findings: bit.ly/40czxRK #AACR23

Congratulations to Dr. Karen Knudsen for being selected for the Forbes 50 over 50: Impact list.  Great to see this well-deserved recognition for Dr. Knudsen's immeasurable contributions to reducing the burden of cancer for all people. @AmerCancerCEO